FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000214249> ?p ?o ?g. }

• W2000214249 endingPage "1247" @default.
• W2000214249 startingPage "1237" @default.
• W2000214249 abstract "To determine the risk of bleeding and supratherapeutic international normalized ratios (INRs) associated with use of complementary and alternative medicine (CAM) in patients receiving warfarin.Prospective, longitudinal study.An acute care, academic and research hospital in Canada.A total of 171 adults who were prescribed warfarin anticoagulation therapy for an expected duration of at least 4 months after enrollment.Patients were asked to complete a 16-week diary by recording bleeding events and exposure to factors previously reported to increase the risk of bleeding and supratherapeutic INRs, including CAM consumption.Prescription, medical, and laboratory records were reviewed. Risk factors for bleeding events and supratherapeutic INR (at least 0.5 units above the target range) were evaluated longitudinally by using generalized estimating equation (GEE) modeling. Of the 171 patients completing a diary, 87 (51%) reported at least one bleeding event and 36 (21%) had a supratherapeutic INR. Seventy-three patients (43%) indicated they had used at least one CAM product previously reported to interact with warfarin. Warfarin use of less than 3 months' duration was the only statistically significant risk factor identified for supratherapeutic INR. The CAM therapies associated with an increased risk of self-reported bleeding included cayenne, ginger, willow bark, St. John's wort, and coenzyme Q(10). Use of more than one CAM while receiving warfarin was also a significant risk factor. Two CAMs were independently associated with an increased risk of self-reported bleeding: coenzyme Q(10) (odds ratio [OR] 3.69, 95% confidence interval [CI] 1.88-7.24) and ginger (OR 3.20, 95% CI 2.42-4.24). Other risk factors significantly associated with increased bleeding included high target INR (2.5-3.5), diarrhea, acetaminophen use, increased alcohol consumption, and increased age.The use of CAM by patients receiving warfarin is common, and consumption of coenzyme Q(10) or ginger appears to increase the risk of bleeding in this population." @default.
• W2000214249 created "2016-06-24" @default.
• W2000214249 creator A5009308068 @default.
• W2000214249 creator A5018942665 @default.
• W2000214249 creator A5041792238 @default.
• W2000214249 creator A5063897112 @default.
• W2000214249 creator A5081943189 @default.
• W2000214249 date "2007-09-01" @default.
• W2000214249 modified "2023-09-25" @default.
• W2000214249 title "Risk of Warfarin-Related Bleeding Events and Supratherapeutic International Normalized Ratios Associated with Complementary and Alternative Medicine: A Longitudinal Analysis" @default.
• W2000214249 cites W1521989421 @default.
• W2000214249 cites W1747593191 @default.
• W2000214249 cites W1769053348 @default.
• W2000214249 cites W1847035519 @default.
• W2000214249 cites W1860738500 @default.
• W2000214249 cites W1975700065 @default.
• W2000214249 cites W1976146074 @default.
• W2000214249 cites W1979365599 @default.
• W2000214249 cites W1981816788 @default.
• W2000214249 cites W1986506316 @default.
• W2000214249 cites W1994920977 @default.
• W2000214249 cites W1995100434 @default.
• W2000214249 cites W2016459663 @default.
• W2000214249 cites W2021781593 @default.
• W2000214249 cites W2021881052 @default.
• W2000214249 cites W2027538725 @default.
• W2000214249 cites W2045120154 @default.
• W2000214249 cites W2052916819 @default.
• W2000214249 cites W2053164513 @default.
• W2000214249 cites W2060313926 @default.
• W2000214249 cites W2072221769 @default.
• W2000214249 cites W2084846354 @default.
• W2000214249 cites W2090510570 @default.
• W2000214249 cites W2095373776 @default.
• W2000214249 cites W2096698984 @default.
• W2000214249 cites W2113989522 @default.
• W2000214249 cites W2126099379 @default.
• W2000214249 cites W2137189209 @default.
• W2000214249 cites W2139798515 @default.
• W2000214249 cites W2150740791 @default.
• W2000214249 cites W2156687558 @default.
• W2000214249 cites W2171487003 @default.
• W2000214249 cites W2197233036 @default.
• W2000214249 cites W2401524019 @default.
• W2000214249 cites W4248660701 @default.
• W2000214249 cites W4252822777 @default.
• W2000214249 cites W4376999658 @default.
• W2000214249 doi "https://doi.org/10.1592/phco.27.9.1237" @default.
• W2000214249 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17723077" @default.
• W2000214249 hasPublicationYear "2007" @default.
• W2000214249 type Work @default.
• W2000214249 sameAs 2000214249 @default.
• W2000214249 citedByCount "104" @default.
• W2000214249 countsByYear W20002142492012 @default.
• W2000214249 countsByYear W20002142492013 @default.
• W2000214249 countsByYear W20002142492014 @default.
• W2000214249 countsByYear W20002142492015 @default.
• W2000214249 countsByYear W20002142492016 @default.
• W2000214249 countsByYear W20002142492017 @default.
• W2000214249 countsByYear W20002142492018 @default.
• W2000214249 countsByYear W20002142492019 @default.
• W2000214249 countsByYear W20002142492020 @default.
• W2000214249 countsByYear W20002142492021 @default.
• W2000214249 countsByYear W20002142492022 @default.
• W2000214249 countsByYear W20002142492023 @default.
• W2000214249 crossrefType "journal-article" @default.
• W2000214249 hasAuthorship W2000214249A5009308068 @default.
• W2000214249 hasAuthorship W2000214249A5018942665 @default.
• W2000214249 hasAuthorship W2000214249A5041792238 @default.
• W2000214249 hasAuthorship W2000214249A5063897112 @default.
• W2000214249 hasAuthorship W2000214249A5081943189 @default.
• W2000214249 hasConcept C126322002 @default.
• W2000214249 hasConcept C141071460 @default.
• W2000214249 hasConcept C156957248 @default.
• W2000214249 hasConcept C197934379 @default.
• W2000214249 hasConcept C2776301958 @default.
• W2000214249 hasConcept C2779161974 @default.
• W2000214249 hasConcept C44249647 @default.
• W2000214249 hasConcept C50440223 @default.
• W2000214249 hasConcept C71924100 @default.
• W2000214249 hasConceptScore W2000214249C126322002 @default.
• W2000214249 hasConceptScore W2000214249C141071460 @default.
• W2000214249 hasConceptScore W2000214249C156957248 @default.
• W2000214249 hasConceptScore W2000214249C197934379 @default.
• W2000214249 hasConceptScore W2000214249C2776301958 @default.
• W2000214249 hasConceptScore W2000214249C2779161974 @default.
• W2000214249 hasConceptScore W2000214249C44249647 @default.
• W2000214249 hasConceptScore W2000214249C50440223 @default.
• W2000214249 hasConceptScore W2000214249C71924100 @default.
• W2000214249 hasIssue "9" @default.
• W2000214249 hasLocation W20002142491 @default.
• W2000214249 hasLocation W20002142492 @default.
• W2000214249 hasOpenAccess W2000214249 @default.
• W2000214249 hasPrimaryLocation W20002142491 @default.
• W2000214249 hasRelatedWork W2057095293 @default.
• W2000214249 hasRelatedWork W2127614605 @default.
• W2000214249 hasRelatedWork W2263197009 @default.
• W2000214249 hasRelatedWork W2550166094 @default.

• next